This summary was created by AI, based on 2 opinions in the last 12 months.
Experts are divided on the prospects of Cameco Corp. (US) with some touting it as the best uranium play, while others are hesitant due to its speculative nature and the challenges facing the uranium industry. The company has seen a significant rally in the past 3 months, but concerns remain about the feasibility of building new nuclear reactors. Overall, the future of Cameco Corp. (US) is uncertain, with both potential for growth and significant risks.
Too speculative though he missed the 21% rally over the past 3 months. Already uranium stocks a headwind in that it's almost impossible to build a nuclear reactor, though some will disagree.
Cameco Corp. (US) is a American stock, trading under the symbol CCJ-N on the New York Stock Exchange (CCJ). It is usually referred to as NYSE:CCJ or CCJ-N
In the last year, 1 stock analyst published opinions about CCJ-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Cameco Corp. (US).
Cameco Corp. (US) was recommended as a Top Pick by on . Read the latest stock experts ratings for Cameco Corp. (US).
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Cameco Corp. (US) In the last year. It is a trending stock that is worth watching.
On 2024-10-31, Cameco Corp. (US) (CCJ-N) stock closed at a price of $52.22.
The best uranium play, and investors now want to invest in uranium.